Clinical trial
TocilizuMab discontinuAtion in GIant Cell Arteritis
NCT06037460 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TocilizuMab discontinuAtion in GIant Cell Arteritis
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- May 13, 2024
- Completion date
- November 30, 2028
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.